Skip to content
Open access

TMEM59 regulates microglial Aβ phagocytosis in a TREM2‐dependent manner and acts as a potential therapeutic target for Aβ amyloidosis

Sep 2026 · Alzheimer's & Dementia · Vol 22 · 0 citations · 55 references
Medicine

Abstract

Microglia‐mediated clearance of amyloid beta (Aβ) is crucial for mitigating Alzheimer's disease (AD) progression, yet the molecular regulators of microglial phagocytosis remain incompletely understood.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.